These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2007-003484-45 PHASE II TRIAL OF FOLFIRI REGIMEN PLUS BEVACIZUMAB ALTERNATED WITH OXALIPLATIN-BASED HEPATIC ARTERIAL INFUSION PLUS DE GRAMONT REGIMEN AND BEVACIZUMAB IN THE TREATMENT OF UNRESECTABLE LIVER METASTASES... not-yet-due
Completed, but no date 2007-003664-22 INTRAPLEURAL PACLITAXEL IN PATIENTS WITH MALIGNANT PLEURAL EFFUSIONS SECONDARY TO OVARIAN CANCER AND OTHER NEOPLASMS bad-data
Ongoing 2007-004053-28 Combined chemio-radioterapy regimen of 5-FU plus irinotecan followed by chemotherapy for the treatment of colorectal cancer with resectable metastases at diagnosis not-yet-due
Ongoing 2011-003509-65 Weekly therapy with Carboplatin and Docetaxel in patients with head-neck cancer with important comorbidity TERAPIA SETTIMANALE CON CARBOPLATINO E DOCETAXEL IN PAZIENTI CON TUMORI CAPO-COLLO CON IMP... not-yet-due
Completed, but no date 2012-002046-20 Role of SAMITAL in prevention and treatment of oral mucositis in patients treated with chemo-radiation (CT/RT)for head-and-neck squamous cell carcinomas. A double-blind, Phase 2 placebo controlled, ra... bad-data
Ongoing 2012-003958-82 Comparison of three different medicines for bowel cleasing for total colonoscopy. Confronto tra differenti sistemi di pulizia del colon per la preparazione alla colonscopia di screening not-yet-due
Completed, but no date Terminated 2012-004058-27 Cytoreductive surgery associated with Hyperthermic Intraperitoneal Chemotherapy versus standard Chemotherapy in the treatment of resectable colorectal carcinomatosis. A multicentric open randomized cl... bad-data
Ongoing 2013-001483-39 XELODA metronomic IN PATIENTS WITH advanced hepatocellular carcinoma AND FUNCTIONALITY 'LIVER CHILD-PUGH B XELODA METRONOMICO NEI PAZIENTI CON EPATOCARCINOMA AVANZATO e FUNZIONALITA' EPATICA CHILD-... not-yet-due
Completed, report not yet due 2013-002511-99 Role of PET/ CT with 18F-fluorocholine in the staging of patients with intermediate/high risk prostate cancer. Phase III, randomized, open-label clinical trial Ruolo della PET/TC con 18F-fluorocoli... 2023-12-31 not-yet-due
Not reported 2013-004153-24 MAINtenance Afinitor (MAIN-A): A randomized trial comparing maintenance aromatase inhibitors (AIs) + everolimus (Afinitor) vs. AIs in patients withHR+ metastatic breast cancer with disease control aft... 2021-03-09 due-trials
Completed, but no date Terminated 2014-002497-37 TIvantinib as Maintenance treatment in Extended Small-cell lung cancer (TIMES) Phase II clinical trial, single arm, two stage Tivantinib come terapia di mantenimento nei pazienti con carcinoma po... bad-data
Completed, but no date 2014-003722-41 Regorafenib in relapsed glioblastoma. REGOMA study Randomized, controlled open‐label phase II clinical trial Regorafenib nella recidiva di glioblastoma. Studio REGOMA Studio clinico di fase II, con... bad-data
Completed, but no date Terminated 2018-001075-20 The METROPHOLYS Study - Metronomic cyclophosphamide vs doxorubicin in elderly patients with advanced soft tissue sarcomas. Randomized, controlled open label clinical trial The METROPHOLYS Study - M... bad-data
Completed, report not yet due 2020-000560-37 Pressurized intraperitoneal aerosol chemotherapy in patients with peritoneal carcinomatosis. PIPAC-IOV study. Single-center, single-arm open-label phase II clinical trial Chemioterapia intraperiton... 2024-06-10 not-yet-due